Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function

PHASE4UnknownINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

July 31, 2021

Study Completion Date

December 31, 2021

Conditions
Diabetes
Interventions
DRUG

NESINA ACT TAB. 25/15mg

Alogliptin/Pioglitazone 25/15mg will be administered to the group once a day in a fixed dose on a fixed schedule for 104 week.

DRUG

AMARYL-M TAB. 2/500mg

Glymepiride/Metformin 2/500mg will be administered to the group once a day in a fixed dose on a fixed schedule for 104 week.

Trial Locations (1)

Unknown

RECRUITING

Kyunghee University Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

collaborator

Kyung Hee University Hospital at Gangdong

OTHER

collaborator

Bucheon St. Mary's Hospital

OTHER

collaborator

Korea University Guro Hospital

OTHER

collaborator

Ajou University School of Medicine

OTHER

collaborator

Inha University Hospital

OTHER

collaborator

Kangbuk Samsung Hospital

OTHER

collaborator

Seoul Medical Center

OTHER

lead

Kyunghee University Medical Center

OTHER